Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

Carrie Haskell-Luevano; Zhimin Xiang; Andrzej M. Wilczynski; Kimberly R. Haskell; Amy M. Andreasen; Sally A. Litherland; William J. Millard; Ira D. Pogozheva; Henry I. Mosberg; Nicholas B. Sorenson

doi:10.1007/978-0-387-73657-0_221

Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

Carrie Haskell-Luevano, Zhimin Xiang, Andrzej M. Wilczynski, Kimberly R. Haskell, Amy M. Andreasen, Sally A. Litherland, William J. Millard, Ira D. Pogozheva, Henry I. Mosberg, Nicholas B. Sorenson

Medicinal Chemistry

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	509-510
Number of pages	2
Journal	Advances in experimental medicine and biology
Volume	611
DOIs	https://doi.org/10.1007/978-0-387-73657-0_221
State	Published - 2009

Bibliographical note

Funding Information:
This work has been supported by NIH Grants to CHL(DK063974, DK57080, DK64250) and to HIM (DA003910) and an ADA Research Award (CHL).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/978-0-387-73657-0_221

Find It

Find It at U of M Libraries

Cite this

Haskell-Luevano, C., Xiang, Z., Wilczynski, A. M., Haskell, K. R., Andreasen, A. M., Litherland, S. A., Millard, W. J., Pogozheva, I. D., Mosberg, H. I., & Sorenson, N. B. (2009). Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans. Advances in experimental medicine and biology, 611, 509-510. https://doi.org/10.1007/978-0-387-73657-0_221

Haskell-Luevano, C, Xiang, Z, Wilczynski, AM, Haskell, KR, Andreasen, AM, Litherland, SA, Millard, WJ, Pogozheva, ID, Mosberg, HI & Sorenson, NB 2009, 'Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.', Advances in experimental medicine and biology, vol. 611, pp. 509-510. https://doi.org/10.1007/978-0-387-73657-0_221

@article{228066812b9e405d81a5f7de7b6416aa,

title = "Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.",

author = "Carrie Haskell-Luevano and Zhimin Xiang and Wilczynski, {Andrzej M.} and Haskell, {Kimberly R.} and Andreasen, {Amy M.} and Litherland, {Sally A.} and Millard, {William J.} and Pogozheva, {Ira D.} and Mosberg, {Henry I.} and Sorenson, {Nicholas B.}",

note = "Funding Information: This work has been supported by NIH Grants to CHL(DK063974, DK57080, DK64250) and to HIM (DA003910) and an ADA Research Award (CHL).",

year = "2009",

doi = "10.1007/978-0-387-73657-0_221",

language = "English (US)",

volume = "611",

pages = "509--510",

journal = "Advances in experimental medicine and biology",

issn = "0065-2598",

publisher = "Springer New York",

}

TY - JOUR

T1 - Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

AU - Haskell-Luevano, Carrie

AU - Xiang, Zhimin

AU - Wilczynski, Andrzej M.

AU - Haskell, Kimberly R.

AU - Andreasen, Amy M.

AU - Litherland, Sally A.

AU - Millard, William J.

AU - Pogozheva, Ira D.

AU - Mosberg, Henry I.

AU - Sorenson, Nicholas B.

N1 - Funding Information: This work has been supported by NIH Grants to CHL(DK063974, DK57080, DK64250) and to HIM (DA003910) and an ADA Research Award (CHL).

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=66349111206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349111206&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-73657-0_221

DO - 10.1007/978-0-387-73657-0_221

M3 - Article

C2 - 19400288

AN - SCOPUS:66349111206

SN - 0065-2598

VL - 611

SP - 509

EP - 510

JO - Advances in experimental medicine and biology

JF - Advances in experimental medicine and biology

ER -

Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this